Can multidrug resistance mechanisms be modified?
Arceci
R J
RJ
Hematology/Oncology, Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA. robert.arceci@chmcc.org
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017209:Apoptosis / Q000502:physiology; D016503:Drug Delivery Systems; D018432:Drug Resistance, Multiple / Q000235:genetics / Q000502:physiology*; D019008:Drug Resistance, Neoplasm / Q000235:genetics / Q000502:physiology*; D019254:Genes, bcl-2 / Q000502:physiology; D006023:Glycoproteins / Q000037:antagonists & inhibitors; D006801:Humans; D051379:Mice; D017211:Treatment Failure; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D006023:Glycoproteins